Itaconic acid indicates cellular but not systemic immune system activation.
dc.contributor.author | Meiser, Johannes | |
dc.contributor.author | Kraemer, Lisa | |
dc.contributor.author | Jaeger, Christian | |
dc.contributor.author | Madry, Henning | |
dc.contributor.author | Link, Andreas | |
dc.contributor.author | Lepper, Philipp M | |
dc.contributor.author | Hiller, Karsten | |
dc.contributor.author | Schneider, Jochen G | |
dc.date.accessioned | 2018-11-08T13:10:12Z | |
dc.date.available | 2018-11-08T13:10:12Z | |
dc.date.issued | 2018-08-14 | |
dc.identifier.issn | 1949-2553 | |
dc.identifier.pmid | 30181801 | |
dc.identifier.doi | 10.18632/oncotarget.25956 | |
dc.identifier.uri | http://hdl.handle.net/10033/621545 | |
dc.description.abstract | Itaconic acid is produced by mammalian leukocytes upon pro-inflammatory activation. It appears to inhibit bacterial growth and to rewire the metabolism of the host cell by inhibiting succinate dehydrogenase. Yet, it is unknown whether itaconic acid acts only intracellularly, locally in a paracrine fashion, or whether it is even secreted from the inflammatory cells at meaningful levels in peripheral blood of patients with severe inflammation or sepsis. The aim of this study was to determine the release rate of itaconic acid from pro-inflammatory activated macrophages | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
dc.subject | Immunology | en_US |
dc.subject | biomarker | en_US |
dc.subject | inflammation | en_US |
dc.subject | itaconic acid | en_US |
dc.subject | metabolism | en_US |
dc.subject | sepsis | en_US |
dc.title | Itaconic acid indicates cellular but not systemic immune system activation. | en_US |
dc.type | Article | en_US |
dc.contributor.department | HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany. | en_US |
refterms.dateFOA | 2018-11-08T13:10:13Z | |
dc.source.journaltitle | Oncotarget |